Akero Therapeutics, Inc.

NASDAQ:AKRO

27.82 (USD) • At close December 31, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q4
Operating Activities:
Net Income -72.705-55.987-53.344-55.186-39.659-31.083-25.831-23.059-35.542-27.403-26.029-32.424-24.33-28.933-15.09-29.711-21.403-16.207-11.886-15.611-15.554-7.228-5.362-61.472-11.148-8.673-0.421-0.96
Depreciation & Amortization -10.1050.0010.0010.0020.0050.0110.0110.010.0110.0110.0110.0110.0090.010.0110.0110.0060-0.103-0.10400000000
Deferred Income Tax 0004.71-3.267-1.443000000.4790.2890.1820.1210.124000-6.46200000000
Stock Based Compensation 7.4687.6567.3986.1165.7394.7984.8444.0411.7314.1613.3112.6422.6122.4362.3641.9161.5461.3231.2370.670.4830.4020.2150.0870.034000
Change In Working Capital -6.191-6.88413.0753.928-12.7125.158-3.044-6.717-1.0153.621-0.3482.5456.7636.221-5.8024.2166.282-7.794-0.6193.3961.8591.504-0.2970.827-0.2680.4190.0830.083
Accounts Receivables 0000000000000000000000000000
Change In Inventory 0000000000000000000000000000
Change In Accounts Payables 10.5691.0936.456-4.2291.3392.876-0.6311.676-0.8532.392-2.247-0.1964.59-2.2981.177-1.2082.11.0010.5880.854-1.5970.881-0.5640.8540.0040.45500
Other Working Capital -16.76-7.9776.6198.157-14.0512.2820.631-8.393-0.1621.2291.8992.7412.1738.519-6.9795.4244.182-8.795-1.2072.5423.4560.6230.267-0.027-0.272-0.0360.0830.083
Other Non Cash Items 11.1094.326-1.326-8.1970.1750.17-0.6120.2180.1910.070.1790.0520.0510.050.050.0490.0670.0940.0546.462-1.5970.881-0.56458.4839.4218.0030-0.178
Operating Cash Flow -70.424-57.453-35.14-48.627-49.719-22.389-24.632-25.508-24.624-19.509-22.876-26.695-14.606-20.034-18.346-23.395-13.508-22.584-11.317-11.649-13.212-5.322-5.444-2.075-1.961-0.251-0.338-1.054
Investing Activities:
Investments In Property Plant And Equipment 000000000000000-0.005-0.14300000000000
Acquisitions Net 000000000000000-0.143000000000000
Purchases Of Investments -57.933-339.407-38.976-58.214-161.197-188.802-24.91-101.4460000-11.907-31.6540-8.996-81.260-24.781-71.51300000000
Sales Maturities Of Investments 13184.5196.8257135.560.542.50.001311.8722.751233.841211926.921.55938.46518.5000000000
Other Investing Activites 0-0.99957.8490.013-0.126-0.1280.018-0.1010.00311.8722.751221.934-10.654190.143-0.14338.465-6.281-71.51300000-500
Investing Cash Flow 73.067-255.89657.84912.786-125.697-128.30217.59-101.445311.8722.751221.934-10.6541917.899-59.84438.465-6.281-71.51300000-500
Financing Activities:
Debt Repayment 0010000150010000000000000000000
Common Stock Issued -11.949-0.15355.4430.5020.806335.4290.1783.061216.225.1320.1320.2430.0690.2660.0240202.55400.05297.0800000000
Common Stock Repurchased 0.32400-11,529.255,750.601000.280000.3730000.1980000.08500000000
Dividends Paid 000-336.855000000000000000000000000
Other Financing Activities 3.067-0.151.495337.3570.8061.4260.1532.7231.724.8770.1320.2430.0690.2660.0240.0590.230.10.1640.1150.02198.2-0.7270.223014.78401.455
Financing Cash Flow 3.067-0.15366.9380.5020.806336.85515.1532.723217.934.8770.1320.2430.0690.2660.0240.059202.7840.10.1640.115-1.60798.2-0.7270.223014.78401.455
Other Information:
Effect Of Forex Changes On Cash 000-5,592.88105,592.8810000000000000000000000
Net Change In Cash 5.71-313.499389.647-35.339-174.61186.1648.111-124.23196.27627.2380.006-14.4527.397-30.4220.678-5.437129.43215.981-17.434-83.047-14.81992.878-6.16468.148-1.9619.533-0.3380.4
Cash At End Of Period 316.065310.355623.854234.207269.546444.156257.992249.881374.111177.835150.597150.591165.043157.646188.068187.39192.82763.39547.41464.848147.895162.71469.836767.8529.8130.280.4